ALXO (ALX Oncology Holdings Inc.) Stock Financials & Earnings

ALXOALX Oncology Holdings Inc.

Mkt Cap$112M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Revenue (TTM)$0

Net Income (TTM)-$102M

EPS (TTM)-$1.90

Free Cash Flow (TTM)-$84M

Gross Margin—

Op. Margin—

Net Margin—

FCF Margin—

P/S Ratio (TTM)—

P/E Ratio (TTM)—

YoY Rev Growth—

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$0	$0	-$32M
Q2 23	$0	$0	-$37M
Q3 23	$0	$0	-$53M
Q4 23	$0	$0	-$48M
Q1 24	$0	-$214K	-$38M
Q2 24	$0	-$220K	-$42M
Q3 24	$0	$0	-$33M
Q4 24	$0	$0	-$31M
Q1 25	$0	$0	-$32M
Q2 25	$0	$0	-$27M
Q3 25	$0	$0	-$23M
Q4 25	$0	$0	-$23M

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Quarter	R&D	G&A	SG&A
Q1 23	$25M	$7M	—
Q2 23	$29M	$7M	—
Q3 23	$46M	$8M	—
Q4 23	$42M	$6M	—
Q1 24	$32M	$6M	—
Q2 24	$35M	$7M	—
Q3 24	$26M	$6M	—
Q4 24	$24M	$7M	—
Q1 25	$24M	$8M	—
Q2 25	$18M	$5M	—
Q3 25	$17M	$5M	—
Q4 25	$18M	—	$5M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$63M	$165M	$228M
Q2 23	$38M	$175M	$213M
Q3 23	$20M	$170M	$190M
Q4 23	$22M	$160M	$183M
Q1 24	$14M	$143M	$157M
Q2 24	$16M	$141M	$157M
Q3 24	$16M	$132M	$149M
Q4 24	$18M	$110M	$128M
Q1 25	$21M	$77M	$98M
Q2 25	$19M	$60M	$79M
Q3 25	$23M	$37M	$61M
Q4 25	$16M	$28M	$45M

Shares Outstanding

Revenue Per Employee

Revenue / Employee